Regulus Files Registration Statement For Proposed IPO - Quick Facts

Alnylam Pharma Q1 Loss Narrows - Quick Facts

Alnylam Pharma To Present At Barclays Global Conference; Webcast At 10:15 AM

Alnylam To Present At Cowen & Co. Conference; Webcast At 8:40 AM ET

Trade ALNY now with

8/20/2012 8:12 AM ET

Regulus Therapeutics Inc., a biopharmaceutical company founded by Alnylam Pharmaceuticals (ALNY: Quote) and Isis Pharmaceuticals (ISIS: Quote), announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by Regulus.

Regulus noted that the number of shares to be offered and the price range for the offering have not yet been determined.

Click here to receive FREE breaking news email alerts for Alnylam Pharmaceuticals Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 131 Articles Next>>

Editors Pick

Stocks Move Higher On Comments From Fed Officials - U.S. Commentary

Stocks have moved mostly higher over the course of the trading day on Tuesday after showing a lack of direction earlier in the session. The major averages have climbed more firmly into positive territory, offsetting the modest losses posted in the previous session. The major averages have moved roughly sideways in recent trading, hovering near their new highs for the session.

Stocks Turning In Another Lackluster Performance - U.S. Commentary

Stocks have shown a lack of direction over the course of the trading day on Tuesday after failing to sustain an early upward move. The choppy trading extends the lackluster performance that was seen throughout the previous session. The major averages are currently posting modest gains but have pulled back off their highs for the session.

Obama's Approval Rating Holding Steady Despite Scandals

While a recent series of scandals have caused headaches for the White House, the results of a Washington Post-ABC News poll released Tuesday suggest that the news has not had an impact on President Barack Obama's approval rating. The poll showed that 51 percent of Americans approve of the way Obama is handling his job as president compared to 44 percent that disapprove.